Shi‐Kwang Lin

417 total citations
11 papers, 288 citations indexed

About

Shi‐Kwang Lin is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Shi‐Kwang Lin has authored 11 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 5 papers in Psychiatry and Mental health and 3 papers in Molecular Biology. Recurrent topics in Shi‐Kwang Lin's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Shi‐Kwang Lin is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Shi‐Kwang Lin collaborates with scholars based in Taiwan and United Kingdom. Shi‐Kwang Lin's co-authors include Wynn H.T. Pan, Chian‐Jue Kuo, Wei-Herng Hu, Hwa‐Sheng Tang, Chiao-Chicy Chen, Tzung‐Jeng Hwang, Wei J. Chen, Hai‐Gwo Hwu, Chao‐Wan Chang and Wen‐Chen Ouyang and has published in prestigious journals such as Schizophrenia Bulletin, Schizophrenia Research and Psychiatric Services.

In The Last Decade

Shi‐Kwang Lin

11 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi‐Kwang Lin Taiwan 7 100 94 70 56 40 11 288
J.-P. Boulenger France 9 193 1.9× 99 1.1× 159 2.3× 75 1.3× 63 1.6× 15 405
Daniel Grupper Israel 6 84 0.8× 90 1.0× 45 0.6× 25 0.4× 26 0.7× 7 302
Matteo Lazzaretti Italy 11 131 1.3× 150 1.6× 50 0.7× 77 1.4× 27 0.7× 21 373
Slađana Štrkalj Ivezić Croatia 9 157 1.6× 123 1.3× 121 1.7× 25 0.4× 66 1.6× 29 360
Derick Vergne United States 8 172 1.7× 61 0.6× 42 0.6× 58 1.0× 54 1.4× 11 325
Irma Kotilainen Finland 4 182 1.8× 152 1.6× 75 1.1× 38 0.7× 33 0.8× 6 330
Nancy Forman United States 4 70 0.7× 113 1.2× 87 1.2× 79 1.4× 39 1.0× 6 340
Lilijana Oruč Bosnia and Herzegovina 12 151 1.5× 132 1.4× 116 1.7× 32 0.6× 77 1.9× 25 437
Lucas L. Dwiel United States 7 110 1.1× 49 0.5× 85 1.2× 71 1.3× 17 0.4× 10 263
David H. Olivier Canada 3 254 2.5× 261 2.8× 25 0.4× 98 1.8× 28 0.7× 7 478

Countries citing papers authored by Shi‐Kwang Lin

Since Specialization
Citations

This map shows the geographic impact of Shi‐Kwang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Kwang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Kwang Lin more than expected).

Fields of papers citing papers by Shi‐Kwang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Kwang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Kwang Lin. The network helps show where Shi‐Kwang Lin may publish in the future.

Co-authorship network of co-authors of Shi‐Kwang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Kwang Lin. A scholar is included among the top collaborators of Shi‐Kwang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Kwang Lin. Shi‐Kwang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lin, Shi‐Kwang, et al.. (2023). Brexpiprazole for the Treatment of Tics in a Patient With Schizophrenia. The Primary Care Companion For CNS Disorders. 25(4). 1 indexed citations
2.
Lin, Shi‐Kwang, et al.. (2020). Drug addiction-the neurochemical perspective of brain in drug-seeking behavior. Journal of Food and Drug Analysis. 11(4). 3 indexed citations
3.
Lin, Shi‐Kwang, et al.. (2006). Prefrontal dopamine efflux during exposure to drug-associated contextual cues in rats with prior repeated methamphetamine. Brain Research Bulletin. 71(4). 365–371. 20 indexed citations
5.
Lin, Shi‐Kwang, et al.. (2006). A single intrategmental amphetamine exposure induces transient behavioral sensitization in the rats.. PubMed. 49(1). 14–21. 2 indexed citations
6.
Pan, Wynn H.T., et al.. (2004). Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse. 53(1). 44–52. 51 indexed citations
7.
Kuo, Chian‐Jue, et al.. (2003). Prevalence of Psychiatric Disorders Among Bereaved Survivors of a Disastrous Earthquake in Taiwan. Psychiatric Services. 54(2). 249–251. 92 indexed citations
8.
Hwu, Hai‐Gwo, Chun‐Houh Chen, Tzung‐Jeng Hwang, et al.. (2002). Symptom patterns and subgrouping of schizophrenic patients: significance of negative symptoms assessed on admission. Schizophrenia Research. 56(1-2). 105–119. 39 indexed citations
9.
Chang, Chao‐Wan, et al.. (2002). Morbidity Risk of Psychiatric Disorders Among the First Degree Relatives of Schizophrenia Patients in Taiwan. Schizophrenia Bulletin. 28(3). 379–392. 54 indexed citations
10.
Lin, Shi‐Kwang, et al.. (2002). Premorbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Research Portal (King's College London). 53(3). 224–224. 6 indexed citations
11.
Hwang, Tzung‐Jeng, et al.. (2001). Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.. PubMed. 100(12). 811–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026